Swisslog Healthcare appoints Brian Roberts as SVP of Medication Management, North America

Brian Roberts, SVP of Medication Management, North America, Swisslog Healthcare

Swisslog Healthcare, a global industry leader in pharmacy and transport automation solutions, announced the appointment of Brian Roberts as the Senior Vice President of Sales and Services in North America for the Medication Management business unit. With a wealth of experience in pharmacy automation, business-to-business healthcare applications, and executive leadership, Roberts brings a proven track record of success to […]

Prothena appoints Daniel G. Welch as Director and Chair Designate

Daniel G. Welch as Director and Chair Designate, Prothena

Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced yesterday the appointment of Daniel G. Welch to its Board of Directors as an independent director and Chair Designate following a comprehensive search process in connection with the board’s regular succession planning. Upon election […]

Gilead Sciences announces the acquisition of CymaBay Therapeutics

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced yesterday a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver […]

Lysando adds Dr. Holger Zimmermann to its advisory board

Dr. Holger Zimmermann – Advisory Board Member Lysando AG

Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, announced the appointment of Dr. Holger Zimmermann to its Advisory Board. Dr. Zimmermann’s distinguished career in the pharmaceutical sector and healthcare industry brings a wealth of experience, positioning him as a key asset in Lysando’s mission to eliminate the fear of harmful bacteria worldwide. Currently […]

Buzzreach and Oncoshot announce collaboration

Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan

Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specializes in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform. The collaboration will extend to Oncoshot’s strategic contract research […]

Vial appoints Emma C. Moran as the new VP of Central Nervous Systems

Emma C. Moran, Vice President of Central Nervous Systems (CNS), Vial

Vial, a global tech-driven CRO providing next-generation clinical trial management services, announced the addition of Emma C. Moran to their team. Moran will be the CRO’s new VP of Central Nervous Systems (CNS), bringing with her an impressive 28-year track record in the clinical research industry. Moran’s expertise spans various domains within the pharmaceutical sector, having worked with both […]

Biocytogen Pharmaceuticals signs a License Agreement With Pheon Therapeutics

Exclusive License Agreement for an Oncological Target Antibody to Develop Best-In-Class ADC

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a global biotech company focusing on the discovery of novel antibody therapeutics, yesterday announced an antibody license agreement with Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next-generation ADCs for a wide range of hard-to-treat cancers. Under the terms of the agreement, Pheon will develop and commercialize an […]

Tagworks Pharmaceuticals announces USD 65Mln in Series A Financing Round

Marc Robillard, Ph.D., is co-founder and CEO of Tagworks

Tagworks Pharmaceuticals BV, the pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates (NEA), and Lightstone Ventures. They join existing investors including Meneldor and Oost NL. In conjunction with the […]

Steven Pilewski joins RQM+ as Chief Operating Officer of Laboratory Services

Steven Pilewski

RQM+, one of the leading MedTech service providers, yesterday announced the appointment of Steven Pilewski as Chief Operating Officer of its Laboratory Services business unit, which provides chemical characterization and reverse chemical engineering (or “deformulation”) of complex products, as well as contaminant and failure investigations for MedTech manufacturers. The business unit was founded more than 4 […]

Rxilient Biotech and Junshi Biosciences partner to develop and commercialize Toripalimab

On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam. Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. […]